Table 1.

Baseline Characteristics of 5 and 10 mg Olanzapine Groups

Baseline Characteristic	Olanzapine group		p
	5 mg (n=70)	10 mg (n=70)
Age, years
Mean (SD)	49 (11.5)	49 (11.3)	0.66
Sex, number
Female/ Male	47/23	47/23	1
Body surface area
Mean (SD)	1.58 (0.19)	1.61 (0.16)	0.28
ECOG performance status, n
0/1	52/18	53/17	0.84
Alcohol use, n (%)			0.18
Current/Former	25 (35.7)	33 (47.1)
Never	45 (64.3)	37 (52.9)
Smoking status, n (%)			0. 35
Current/Former	18 (25. 7)	23 (32. 9)
Never	52 (74. 3)	47 (67. 1)
History of motion sickness, n (%)	19 (27.1)	19 (27.1)	1
History of morning sickness, n (%)	17 (24.2)	20 (28.5)	0. 52
Primary tumor, n (%)			0.39
Breast	41 (58.6)	43 (61.4)
Head-neck	25 (35.7)	26 (37.1)
Others	4 (5.7)	1 (1.4)
Chemotherapy regimen, n (%)			0.73
AC	41 (58.6)	43 (61.4)
Cisplatin	29 (41.4)	27 (38.6)
Cisplatin dose, mg/m2
Mean (SD)	74.2 (2.8)	75.4 (3.2)	0.17
Radiotherapy, n (%)	4 (5.7)	2 (2.9)	0.39